Howard W. Robin

President & Chief Executive Officer at Nektar Therapeutics

Howard W. Robin

Howard W. Robin

President & Chief Executive Officer at Nektar Therapeutics

Overview
Career Highlights

Berlex Laboratories, Inc.
Berlex, Inc.
Nektar Therapeutics

RelSci Relationships

1024

Number of Boards

7

Birthday

1953

Age

66

Contact Data
Trying to get in touch with Howard W. Robin? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Howard W. Robin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice Chairman, President & Chief Executive Officer at Schering Berlin, Inc.

Relationship likelihood: Strong

Founder at Numenor Ventures LLC

Relationship likelihood: Strong

Lecturer in Management at Stanford University - Stanford Graduate School of Business

Relationship likelihood: Strong

Senior Vice President & Chief Operating Officer at Nektar Therapeutics

Relationship likelihood: Strong

Co-Founder at Incyte Corp.

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

University Provost & Senior Vice President Academic Affairs at Fairleigh Dickinson University

Relationship likelihood: Strong

Director & Vice Chairman-Food Governing Body at Biotechnology Innovation Organization

Relationship likelihood: Strong

Executive Vice President & Chief Commercial Officer at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Strong

Former Executive Chairman of the Board & Interim Chief Executive Officer at EXACT Sciences Corp.

Relationship likelihood: Strong

Paths to Howard W. Robin
Potential Connections via
Relationship Science
You
Howard W. Robin
President & Chief Executive Officer at Nektar Therapeutics
Education
B.S. in Accounting & Finance
Class of 1974

Fairleigh Dickinson University is a private, coeducational and nonsectarian university founded in 1942. Fairleigh Dickinson University is the first American university to own and operate an international campus and currently offers more than 100 individual degree programs to its students. The school has four campuses, two in New Jersey (United States), and one in Canada and in the United Kingdom. Fairleigh Dickinson University is New Jersey's largest private institution of higher education with 12,000+ students. The university has two campuses in New Jersey: the College at Florham in Madison, which is on the former estate of Florence Vanderbilt and Hamilton Twombly, and the Metropolitan Campus, close to New York City and spanning the Hackensack River in Teaneck and Hackensack.

Career History
President & Chief Executive Officer
2007 - Current

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.

President, Chief Executive Officer & Director
2001 - 2006

Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA.

Corporate Vice President & General Manager
1991 - Prior

Berlex Laboratory

Boards & Committees
Director
Prior

BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute’s work in science education, career development and entrepreneurship.

Transactions
Details Hidden

Merck & Co., Inc. purchases Sirna Therapeutics, Inc.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
New York City, NY
2013 UBS Global Healthcare Conference

Speaker
Grand Hyatt New York-New York, NY
2012 UBS Global Life Sciences Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Howard W. Robin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Howard W. Robin's profile does not indicate a business or promotional relationship of any kind between RelSci and Howard W. Robin.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/howard-w-robin-3279565
  • https://relationshipscience.com/person/howard-w-robin-3279565